Organigram Global Inc Asset Turnover Ratio (OGI), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Organigram Global Inc   (NASDAQ: OGI)
 

Organigram Global Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Organigram Global Inc asset turnover ratio, the ability of Organigram Global Inc 's assets to generate revenue in the fourth quarter 2025, increased sequentially to 0.46 in the fourth quarter (Sep 30 2025), a new company high.

Within sector 84 more businesses have achieved higher asset turnover ratio. While asset turnover ranking remained unchanged in the fourth quarter 2025 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OGI Asset Turnover Ratio (Sep 30 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Sep 30 2024)
IV. Quarter
Y / Y Asset Change 53.38 % 53.38 % 53.38 % 53.38 % 33.67 %
Y / Y Revenue Change 62.15 % - - - 9.62 %
Asset Turnover Ratio (TTM) 0.46 - - - 0.44
OGI's Total Ranking # # # # 2872 #
Seq. Asset Change 0 % 0 % 0 % 53.38 % 0 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 85
Healthcare Sector # 311
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0.46 0.43 0.39
(Sep 30 2025)   (Sep 30 2024)




OGI Company Profile • Back to OGI Efficiency Comparisons • Compare OGI Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2025 Assets at quarter ending Sep 30 2025
Ardent Health Inc   1.26 $ 6,325.549  Millions$ 5,012.246  Millions
Idexx Laboratories Inc  1.26 $ 4,166.125  Millions$ 3,306.159  Millions
Hca Healthcare Inc   1.25 $ 74,372.000  Millions$ 59,648.500  Millions
Electromed Inc   1.24 $ 65.500  Millions$ 53.025  Millions
Warby Parker Inc   1.23 $ 849.660  Millions$ 692.016  Millions
Precipio inc   1.22 $ 22.800  Millions$ 18.687  Millions
Natera Inc   1.21 $ 2,116.674  Millions$ 1,742.912  Millions
Henry Schein Inc   1.21 $ 12,938.000  Millions$ 10,675.250  Millions
Sunshine Biopharma Inc   1.21 $ 37.324  Millions$ 30.800  Millions
Zynex inc   1.21 $ 108.253  Millions$ 89.774  Millions
Healthlynked Corp  1.20 $ 2.374  Millions$ 1.973  Millions
Exagen Inc   1.20 $ 61.719  Millions$ 51.642  Millions
Elite Pharmaceuticals Inc   1.19 $ 121.713  Millions$ 102.157  Millions
Sonoma Pharmaceuticals Inc   1.19 $ 16.937  Millions$ 14.221  Millions
Regen Biopharma Inc   1.18 $ 0.237  Millions$ 0.201  Millions
Mettler toledo International Inc   1.18 $ 3,941.791  Millions$ 3,349.152  Millions
Trisalus Life Sciences Inc   1.16 $ 37.905  Millions$ 32.594  Millions
Pro dex Inc   1.16 $ 70.231  Millions$ 60.560  Millions
Neuroone Medical Technologies Corp  1.16 $ 9.098  Millions$ 7.858  Millions
The Pennant Group Inc   1.16 $ 847.274  Millions$ 732.051  Millions
Karyopharm Therapeutics Inc   1.16 $ 142.530  Millions$ 123.310  Millions
Sanara Medtech Inc   1.14 $ 101.008  Millions$ 88.582  Millions
Universal Health Services Inc   1.14 $ 16,992.503  Millions$ 14,918.670  Millions
Apellis Pharmaceuticals Inc   1.14 $ 1,016.396  Millions$ 893.112  Millions
Inogen Inc   1.13 $ 347.028  Millions$ 305.912  Millions
Inspire Medical Systems inc   1.12 $ 881.480  Millions$ 787.275  Millions
Tactile Systems Technology Inc   1.12 $ 310.509  Millions$ 277.598  Millions
Phibro Animal Health Corporation  1.11 $ 1,400.230  Millions$ 1,261.467  Millions
Tandem Diabetes Care Inc   1.11 $ 1,005.832  Millions$ 910.048  Millions
Evofem Biosciences Inc   1.09 $ 17.726  Millions$ 16.214  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.